Company research
Eton Pharmaceuticals, Inc.
CIK 1710340Updated Sep 24, 2026
SecurityETON · NASDAQ · equity
ETON price & chart
Loading TradingView…
NASDAQ:ETON on TradingView ↗In the news
Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 ↗
Recent filings
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 92,114,000Source | 76,123,000Source | 31,740,000Source | 25,030,000Source |
| Property, Plant and Equipment, NetUSD | 326,000Source | 34,000Source | 58,000Source | 72,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 30,878,000Source | 34,881,000Source | 4,739,000Source | 4,754,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 25,942,000Source | 14,936,000Source | 21,388,000Source | 16,305,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 11,757,000Source | 5,361,000Source | 3,411,000Source | 1,852,000Source |
| Inventory, NetUSD | 15,419,000Source | 15,232,000Source | 911,000Source | 557,000Source |
| Assets, CurrentUSD | 60,581,000Source | 41,021,000Source | 26,839,000Source | 20,004,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 7,463,000Source | 5,492,000Source | 1,129,000Source | 1,290,000Source |
| Operating Lease, Right-of-Use AssetUSD | 310,000Source | 175,000Source | 92,000Source | 188,000Source |
| Other Assets, NoncurrentUSD | 19,000Source | 12,000Source | 12,000Source | 12,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 65,960,000Source | 51,695,000Source | 16,263,000Source | 11,952,000Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 27,000Source | 27,000Source | 26,000Source | 25,000Source |
| Retained Earnings (Accumulated Deficit)USD | -112,494,000Source | -107,893,000Source | -104,070,000Source | -103,134,000Source |
| Stockholders' Equity Attributable to ParentUSD | 26,154,000Source | 24,428,000Source | 15,477,000Source | 13,078,000Source |
| Additional Paid in Capital, Common StockUSD | 138,621,000Source | 132,294,000Source | 119,521,000Source | 116,187,000Source |
| Liabilities and EquityUSD | 92,114,000Source | 76,123,000Source | 31,740,000Source | 25,030,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 38,490,000Source | 19,947,000Source | 16,241,000Source | 6,461,000Source |
| Operating Lease, Liability, CurrentUSD | 65,000Source | 76,000Source | — | 75,000Source |
| Accounts Payable, CurrentUSD | 10,976,000Source | 4,167,000Source | 1,848,000Source | 1,766,000Source |
| Operating Lease, Liability, NoncurrentUSD | 460,000Source | 107,000Source | 22,000Source | 107,000Source |
| Other Liabilities, NoncurrentUSD | 5,241,000Source | 1,830,000Source | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 9,408,000Source | 8,914,000Source | 9,013,000Source | 3,662,000Source |
| Deferred Tax Liabilities, NetUSD | 0Source | 0Source | — | — |
| Long-term Debt, Current MaturitiesUSD | 8,789,000Source | 0Source | 5,380,000Source | 1,033,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 21,769,000Source | — | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | 66,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 5,512,000Source | 3,165,000Source | 3,137,000Source | 4,218,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 6,396,000Source | 3,118,000Source | 1,559,000Source | -3,619,000Source |
| Increase (Decrease) in InventoriesUSD | 5,876,000Source | 1,310,000Source | 354,000Source | 7,000Source |
| Increase (Decrease) in Accounts PayableUSD | 6,808,000Source | 2,318,000Source | 53,000Source | -8,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 10,524,000Source | 969,000Source | 6,815,000Source | 4,821,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -333,000Source | -40,014,000Source | -775,000Source | -2,788,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 333,000Source | 26,000Source | 0Source | 38,000Source |
| Cash flows from financing activities: | ||||
| Payment, Tax Withholding, Share-based Payment ArrangementUSD | 0Source | 0Source | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 815,000Source | 32,593,000Source | -957,000Source | -134,000Source |
| Repayments of Long-term DebtUSD | 0Source | 1,155,000Source | — | — |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 11,006,000Source | -6,452,000Source | 5,083,000Source | 1,899,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 3,325,000Source | 665,000Source | 842,000Source | 730,000Source |
| Income Taxes Paid, NetUSD | 118,000Source | 82,000Source | 247,000Source | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 5,512,000Source | 3,165,000Source | 3,137,000Source | — |
| Amortization of Intangible AssetsUSD | 4,003,000Source | 1,096,000Source | 790,000Source | 1,617,000Source |
| DepreciationUSD | 41,000Source | 50,000Source | 44,000Source | — |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | 0Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | 0Source | — |
| General and Administrative ExpenseUSD | 35,819,000Source | 22,753,000Source | 18,931,000Source | 18,582,000Source |
| Income Tax Expense (Benefit)USD | 43,000Source | 15,000Source | 247,000Source | — |
| Inventory Write-downUSD | 594,000Source | — | — | 62,000Source |
| Net Income (Loss) Attributable to ParentUSD | -4,601,000Source | -3,823,000Source | -936,000Source | -9,021,000Source |
| Nonoperating Income (Expense)USD | -3,714,000Source | -1,211,000Source | 503,000Source | -761,000Source |
| Operating ExpensesUSD | 43,584,000Source | 26,008,000Source | 22,253,000Source | 22,578,000Source |
| Operating Lease, ExpenseUSD | — | — | 77,000Source | 87,000Source |
| Proceeds from Issuance of Long-term DebtUSD | 0Source | 25,309,000Source | — | — |
| Proceeds from Stock Options ExercisedUSD | 598,000Source | 1,191,000Source | 149,000Source | 251,000Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 79,950,000Source | 39,011,000Source | 31,642,000Source | 21,251,000Source |
| Cost of RevenueUSD | 37,210,000Source | 15,600,000Source | 10,581,000Source | 6,933,000Source |
| Operating Income (Loss)USD | -844,000Source | -2,597,000Source | -1,192,000Source | -8,260,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -4,558,000Source | -3,808,000Source | -689,000Source | -9,021,000Source |
| Income Tax Expense (Benefit)USD | 43,000Source | 15,000Source | 247,000Source | — |
| Net Income (Loss) Attributable to ParentUSD | -4,601,000Source | -3,823,000Source | -936,000Source | -9,021,000Source |
| Earnings Per Share, BasicUSD per share | -0.17Source | -0.15Source | -0.04Source | -0.36Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 26,907,725Source | 25,895,086Source | 25,645,366Source | 25,145,657Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 4,003,000Source | 1,096,000Source | 790,000Source | 1,617,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 4,044,000Source | 1,146,000Source | 901,000Source | 1,774,000Source |
| General and Administrative ExpenseUSD | 35,819,000Source | 22,753,000Source | 18,931,000Source | 18,582,000Source |
| Gross ProfitUSD | 42,740,000Source | 23,411,000Source | 21,061,000Source | 14,318,000Source |
| Interest ExpenseUSD | — | — | 1,060,000Source | 955,000Source |
| Interest Expense, DebtUSD | 4,781,000Source | 2,005,000Source | 1,023,000Source | — |
| Nonoperating Income (Expense)USD | -3,714,000Source | -1,211,000Source | 503,000Source | -761,000Source |
| Operating ExpensesUSD | 43,584,000Source | 26,008,000Source | 22,253,000Source | 22,578,000Source |
| Operating Lease, ExpenseUSD | — | — | 77,000Source | 87,000Source |
| Research and Development ExpenseUSD | 7,765,000Source | 3,255,000Source | 3,322,000Source | 3,996,000Source |